Table 1.
Characteristic | No. of Patients | % | Patients Who Received Brachytherapy (%) | P* |
---|---|---|---|---|
Total No. of patients | 29,648 | 15.8 | ||
Age at breast-conserving surgery, years | .95 | |||
66-69 | 7,879 | 26.6 | 16.0 | |
70-74 | 8,835 | 29.8 | 15.7 | |
75-79 | 6,871 | 23.2 | 15.6 | |
80-84 | 4,435 | 15.0 | 15.8 | |
85-94 | 1,628 | 5.5 | 15.5 | |
Race | .11 | |||
White | 27,050 | 91.2 | 15.9 | |
Black | 1,787 | 6.0 | 14.1 | |
Other | 811 | 2.7 | 14.9 | |
Year of surgery | .66 | |||
2008 | 19,304 | 65.1 | 15.7 | |
2009 | 10,344 | 34.9 | 15.9 | |
Residence in metro county | < .001 | |||
Yes | 23,913 | 80.7 | 16.4 | |
No | 5,735 | 19.3 | 13.2 | |
Median household income | < .001 | |||
Q1 (≤ $33,208) | 5,724 | 19.3 | 15.4 | |
Q2 ($33,209-$39,659) | 5,723 | 19.3 | 14.5 | |
Q3 ($39,661-$47,295) | 5,728 | 19.3 | 16.0 | |
Q4 ($47,300-$60,118) | 5,727 | 19.3 | 16.1 | |
Q5 (≥ $60,124) | 5,723 | 19.3 | 16.0 | |
Unknown | 1,023 | 3.5 | 19.9 | |
Comorbidity | .41 | |||
0 conditions | 16,925 | 57.1 | 15.6 | |
1-2 conditions | 10,478 | 35.3 | 16.1 | |
≥ 3 conditions | 2,245 | 7.6 | 15.1 | |
Tumor laterality | < .001 | |||
Right-sided | 12,527 | 42.3 | 15.8 | |
Left-sided | 12,828 | 43.3 | 16.6 | |
Unknown | 4,293 | 14.5 | 13.3 | |
Type of radiation facility | .01 | |||
Hospital-based | 18,221 | 61.4 | 15.3 | |
Free-standing | 11,435 | 38.6 | 16.4 | |
Axillary node dissection | < .001 | |||
No | 8,684 | 29.3 | 12.1 | |
Yes | 20,964 | 70.7 | 17.3 | |
Chemotherapy | < .001 | |||
No chemotherapy | 25,956 | 87.6 | 16.4 | |
Chemotherapy started in month prior through month after surgery | 1,211 | 4.1 | 7.0 | |
Chemotherapy started in 31-365 days after surgery | 2,481 | 8.4 | 13.3 | |
Hospital admission† | .005 | |||
No | 25,671 | 86.6 | 16.0 | |
Yes | 3,977 | 13.4 | 14.2 | |
Screening mammogram† | < .001 | |||
No | 6,840 | 23.1 | 13.5 | |
Yes | 22,808 | 76.9 | 16.4 | |
Flu shot† | .13 | |||
No | 12,440 | 42.0 | 15.4 | |
Yes | 17,208 | 58.0 | 16.0 | |
Visit to primary care physician† | .002 | |||
No | 876 | 3.0 | 12.0 | |
Yes | 28,772 | 97.1 | 15.9 |
P value is for χ2 test between each covariate and receipt of brachytherapy.
In the year before breast-conserving surgery.